Top Story

Higher UV radiation linked to increased prevalence of nonmelanoma skin cancers

August 20, 2014

Higher mean daily UV radiation was associated with increased non-melanoma skin cancer incidence rates, according to study findings.

Researchers systematically reviewed 40 peer-reviewed articles published from 1978 to 2012 that provided age- and sex-specific and incidence data for non-melanoma skin cancers in white populations worldwide.

figure In the Journals

High-mitotic rate melanoma linked to patient, tumor characteristics

August 20, 2014
Melanomas with higher mitotic rates occurred more frequently in men and in individuals aged older than 70 years, according to results of a cross-sectional study.These…
In the JournalsPerspective

Smoking habits persisted among cancer survivors

August 6, 2014
Nearly one-tenth of cancer survivors continued to smoke 9 years after diagnosis, according to results of a population-based study.Among that group, 83% were categorized…
In the Journals

Screening identifies gene mutation frequency in female genital-tract melanomas

August 1, 2014
In a study evaluating the occurrence of certain gene mutations in female genital-tract melanomas, KIT, NRAS and BRAF mutations were identified most frequently, according…
CME

Molecular Testing as the Basis for Targeted Therapies in NSCLC

Supported by an independent educational grant from Boehringer Ingelheim.

3/17/2014
NSCLC comprises approximately 85% of all lung cancer cases. NSCLC histologies are primarily adenocarcinoma, squamous…
More »

MPN Updates

This electronic newsletter is sponsored by Incyte Corp. through a third-party independent grant.

1/8/2014
As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay…
More »

Filter By:

In the Journals

Higher UV radiation linked to increased prevalence of nonmelanoma skin cancers

August 20, 2014
Higher mean daily UV radiation was associated with increased non-melanoma skin cancer incidence rates, according to study findings.Researchers…
figure In the Journals

High-mitotic rate melanoma linked to patient, tumor characteristics

August 20, 2014
Melanomas with higher mitotic rates occurred more frequently in men and in individuals aged older than 70 years, according to results of a…
In the Journals Perspective

Smoking habits persisted among cancer survivors

August 6, 2014
Nearly one-tenth of cancer survivors continued to smoke 9 years after diagnosis, according to results of a population-based study.Among that group…
In the Journals

Screening identifies gene mutation frequency in female genital-tract melanomas

August 1, 2014
In a study evaluating the occurrence of certain gene mutations in female genital-tract melanomas, KIT, NRAS and BRAF mutations were identified most…
Industry News

FDA Commissioner responds to Call to Action for skin cancer prevention

July 29, 2014
U.S. Food and Drug Administration Commissioner Margaret A. Hamburg has released a statement regarding the Surgeon General’s Call to Action to…
In the Journals

Lymphovascular invasion, regression novel prognostic factors in thin melanomas

July 18, 2014
Lymphovascular invasion and extensive regression independently predicted survival in patients with thin melanomas, according to study results.The…
Industry News

Zelboraf plus cobimetinib extended PFS in BRAF V600-positive melanoma

July 15, 2014
The addition of the BRAF inhibitor vemurafenib to the MEK inhibitor cobimetinib significantly improved progression-free survival in patients with…
In the Journals

Excision rates lower in middle-aged patients with keratinocyte cancer

July 8, 2014
In a study to assess treatment trends for keratinocyte cancers, researchers found that whereas overall treatment rates have increased significantly…
In the Journals

Two mutations linked to success of adoptive T-cell therapy in melanoma

July 8, 2014
Two novel mutations, KIF2C and POLA2, appeared to be linked to complete cancer regression in two patients with metastatic melanoma who underwent…
Industry News

European Commission approves Mekinist for metastatic melanoma

July 7, 2014
The European Commission has given marketing authorization for trametinib as monotherapy for unresectable or metastatic melanoma in adults with a…
More Headlines »